Stock screener

SLN

Conviction 80HealthcareScan · Tue, Sep 8, 2026
SLN$13.69-6.17%
ResistanceSupportVol 14Insider sell
63 bars
10
2
Vol MA14 700.27K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Silence Therapeutics plcPHARMACEUTICAL PREPARATIONSwww.silence-therapeutics.com
Price13.69
Change-6.17%
Gap-4.80%
Rel volume0.80×
Avg volume1.23M
Avg $ vol17.21M
SMA 2013.90
SMA 5012.13
SMA 2007.71
Price vs 50+12.90%
Price vs 200+77.50%
MA stackbullish
50/200 cross
Supertrendup · 12.14
RSI (14)54
MACD hist-0.07
MACD cross
Stoch %K / %D30 / 59
ADX (14)44
+DI / −DI28 / 17
RSI divergence
MACD divergence
ATR %+6.50%
ADR %5.92%
52w high15.43
52w low4.30
From 52w high-11.28%
Above 52w low+218.37%
New 52w highNo
SqueezeOff
Bollinger width15.78%
%B0.40
Donchian pos19.35%
Donchian high16.52
Donchian low13.01
AVWAP (52w high)14.82
vs AVWAP high-7.64%
AVWAP (52w low)11.27
vs AVWAP low+21.47%
OBV trendDown
Chaikin MF (20)-0.28
Today vs 20d0.80×
Avg vol (14d)700.27K
Avg vol (20d)1.23M
Avg $ vol (20d)17.21M
Market cap1.94B
RS 3m (vs SPY)+132.04%
RS 6m (vs SPY)+119.64%
RS line new highNo
Trend template8/8
Technical rank76.7
1 week+1.18%
1 month+14.56%
3 months+119.74%
6 months+121.16%
1 year+140.60%
YTD+122.60%
P/E-21.90
P/B50.44
P/S
P/FCF-31.13
EPS-0.6300
Div yield
ROE-230.33%
ROA-83.27%
Debt/Eq
Current7.42
EV/EBITDA
Gross margin61.54%
Net margin
Rev growth-98.71%
EPS growth-95.57%
Price target37.00
Target upside170.27%
Analyst ratingBuy
Institutional12.32%
Ent. value1.87B
Revenue0
Net income-12.27M
Gross profit0
Free cash flow-62.33M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out47.23M
Employees88
ListedTue, Sep 8, 2020
Free float15.06M
Float %10.6%
Short interest2.43M
Days to cover0.8d
Short volume46.1%
Squeeze score41 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.26 vs −$0.32
Last surprise+18.8% beat
Setup gradeA
Conviction80 / 100
Pattern quality
Tech rank76.7 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance16.43
Support10.44
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SLN

All disclosures →
No recent disclosed trades by Congress in SLN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLN · 10 sells

InsiderSideShares
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell2.79M
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell100K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell50K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell3.5K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell800K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell382K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell470.82K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell605.17K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell120K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell60K

SEC filings

EDGAR filings in SLN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.